Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
d-panthenol + methylcobalamin + pyridoxine + thiamine
- Development stage
- Unknown
- Lead developer
- Croise Pharma
- Modality
- Small Molecules
- Administration
- Intramuscular, Intravenous
01
Overview
NEGLOW-TM is an injectable nutritional supplement combination developed by Croise Pharma. It contains d-panthenol (provitamin B5), methylcobalamin (active form of vitamin B12), pyridoxine (vitamin B6), and thiamine (vitamin B1). This combination is primarily indicated for the treatment and prevention of nutritional deficiencies, vitamin B-complex deficiencies, and associated neurological complications such as peripheral neuropathy, diabetic neuropathy, and anemia. By delivering these essential vitamins directly into the bloodstream, NEGLOW-TM bypasses the digestive tract to ensure rapid absorption, promoting nerve repair, improving energy metabolism, and supporting overall cellular health.
- Brand names
- NEGLOW-TM
- Other names
- d-panthenol + methylcobalamin + pyridoxine + thiamined-panthenol + methylcobalamin + pyridoxine hydrochloride + thiaminemethylcobalamin + pyridoxine + thiamine + d-panthenolmethylcobalamin + pyridoxine hydrochloride + thiamine + d-panthenolmethylcobalamin + pyridoxine hydrochloride + thiamine (vitamin b1) + d-panthenol
02
Targets
MTR (Methionine synthase)MMUT (Methylmalonyl-coenzyme A mutase)PDHA1 (Pyruvate dehydrogenase E1 component subunit alpha 1)
Beyond the preview
Go deeper on d-panthenol + methylcobalamin + pyridoxine + thiamine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on d-panthenol + methylcobalamin + pyridoxine + thiamine.